Cover Image
市場調查報告書

難治性白血病:全球臨床實驗檢討

Refractory Leukemia Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 299736
出版日期 內容資訊 英文 82 Pages
訂單完成後即時交付
價格
Back to Top
難治性白血病:全球臨床實驗檢討 Refractory Leukemia Global Clinical Trials Review, H1, 2014
出版日期: 2014年04月15日 內容資訊: 英文 82 Pages
簡介

本報告提供難治性白血病的治療藥相關臨床實驗調查分析,臨床實驗數及被實驗人數,各階段及Phase別狀況,彙整有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗上難治性白血病的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:腫瘤科臨床實驗上難治性白血病的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

Phase別臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與難治性白血病治療藥臨床實驗的主要企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Sanofi
    • 大塚製藥
    • Teva Pharmaceutical Industries Limited
    • Spectrum Pharmaceuticals, Inc.
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Bristol-Myers Squibb Company
    • BioCryst Pharmaceuticals, Inc.
    • AEterna Zentaris Inc.
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • The University of Texas M. D. Anderson Cancer Center
    • Sidney Kimmel Comprehensive Cancer Center
    • Fred Hutchinson Cancer Research Center
    • National Institutes of Health Clinical Center
    • Seattle Children's Hospital, Research and Foundation
    • Children's Oncology Group
    • Case Comprehensive Cancer Center

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2083CTIDB

GlobalData's clinical trial report, "Refractory Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Refractory Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Refractory Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Refractory Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Refractory Leukemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Refractory Leukemia to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Refractory Leukemia to Oncology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Refractory Leukemia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Refractory Leukemia Therapeutics Clinical Trials
  • Prominent Drugs
    • Clinical Trial Profiles
      • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Otsuka Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd.
      • Teva Pharmaceutical Industries Limited
      • Clinical Trial Overview of Teva Pharmaceutical Industries Limited
      • Spectrum Pharmaceuticals, Inc.
      • Clinical Trial Overview of Spectrum Pharmaceuticals, Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • BioCryst Pharmaceuticals, Inc.
      • Clinical Trial Overview of BioCryst Pharmaceuticals, Inc.
      • AEterna Zentaris Inc.
      • Clinical Trial Overview of AEterna Zentaris Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Sidney Kimmel Comprehensive Cancer Center
      • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
      • Fred Hutchinson Cancer Research Center
      • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
      • National Institutes of Health Clinical Center
      • Clinical Trial Overview of National Institutes of Health Clinical Center
      • Seattle Children's Hospital, Research and Foundation
      • Clinical Trial Overview of Seattle Children's Hospital, Research and Foundation
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Refractory Leukemia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Refractory Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Refractory Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Refractory Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Refractory Leukemia to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Refractory Leukemia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Refractory Leukemia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Refractory Leukemia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Refractory Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, Research and Foundation, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014*

List of Figures

  • Refractory Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Refractory Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Refractory Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Refractory Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Refractory Leukemia to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Refractory Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Refractory Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Refractory Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top